SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: JOEBT1 who wrote (11539)11/20/1997 3:34:00 PM
From: Andrew H  Read Replies (1) | Respond to of 32384
 
Joe--you are probably correct about this being a buying op. As far as news goes, however, I don't think the delay in the deal should prevent news about Panretin and Targretin (for non-metabolic indications) from being released.

If last year is any indication, I think this was the last week that LGND and many bios were in their slump. The move up last year began in the coming week. Let's hope this year is the same.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News